Delivery Order SPE2DB20D1100-SPE2DB25FD9K5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management, aligning with the company's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $1,610.79 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 15, 2025, with completion targeted for September 16, 2025. This is a firm fixed price delivery order issued under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The Dexcom G7 is a continuous glucose monitoring system used for...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.76 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,295.99 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 12, 2025, with a completion date of August 13, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dexcom G7 sensors are continuous glucose monitoring devices used for diabetes management, supporting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 5, 2025, with a completion date of August 6, 2025. The contract utilizes firm fixed pricing and was competitively awarded without set-aside provisions. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The Dexcom G7 is a continuous glucose monitoring...
- The Defense Logistics Agency awarded a $2,280.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,062.40 for Dexcom G7 sensors on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The sensors will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Dexcom G7 is a continuous glucose monitoring system...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,237.44 to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a firm fixed-price contract, with an ultimate completion date of September 15, 2025. This is a non-set-aside award issued competitively on September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serve as the prime contractor for this order. The Dexcom G7 is a continuous...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.84 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 25, 2025, with completion scheduled for August 26, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in pharmaceutical products...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9K5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors under contract 4569029682, valued at $1,031.20 with a firm fixed price structure. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management, reflecting the Defense Logistics Agency's ongoing procurement of medical devices and pharmaceuticals to support military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's larger IDC vehicle (SPE2DX) with DLA valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that supplies a comprehensive range of medical products including specialty medications, vaccines, medical devices, and diagnostic supplies across multiple therapeutic domains. The company's role as a prime vendor through this DLA contract underscores its critical position in the federal medical supply chain supporting Defense Health Agency operations and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/8/25 |